No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MED Medifast
- 25.740
- -0.360-1.38%
Close May 31 16:00 ET
- 25.420
- -0.320-1.24%
Post 19:16 ET
281.52MMarket Cap4.16P/E (TTM)
26.530High24.830Low742.27KVolume26.360Open26.100Pre Close19.02MTurnover7.48%Turnover Ratio2.83P/E (Static)10.94MShares107.29352wk High1.33P/B255.37MFloat Cap22.35052wk Low3.30Dividend TTM9.92MShs Float298.445Historical High12.82%Div YieldTTM6.51%Amplitude-1.875Historical Low25.628Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Looking Into Medifast's Recent Short Interest
Medifast's (NYSE:MED) short percent of float has risen 3.9% since its last report. The company recently reported that it has 3.24 million shares sold short, which is 45.02% of all regular shares that
Medifast, Beauty Health Among Consumer Staples Additions in Russell Microcap; PLBY Group, Rocky Mountain Chocolate Removed
Investors Could Be Concerned With Medifast's (NYSE:MED) Returns On Capital
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting Its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
GLP-1 Lifestyle Program brings together clinician-prescribed medications, coach support and new GLP-1 Nutrition Support Kit designed for medication users National advertising campaign with planned $30 million
(MED) - Analyzing Medifast's Short Interest
Medifast's (NYSE:MED) short percent of float has risen 11.91% since its last report. The company recently reported that it has 2.99 million shares sold short, which is 41.53% of all regular shares tha
Lacklustre Performance Is Driving Medifast, Inc.'s (NYSE:MED) 27% Price Drop
Unfortunately for some shareholders, the Medifast, Inc. (NYSE:MED) share price has dived 27% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a y
Comments
Insider share sale and more insider sales than purchases over the past year may raise concerns. Low insider ownership in Medifast could suggest a lack of long-term incentive to grow the company.
2
1
$NVIDIA(NVDA.US$
check out this company!!
$Medifast(MED.US$
96.7% institutional ownership
17.9% float sold short
p/e ratio: 4.46
dividend: 13%
0 debt
150 m in cash
established: 1981
$Tesla(TSLA.US$
check out this company!!
$Medifast(MED.US$
96.7% institutional ownership
17.9% float sold short
p/e ratio: 4.46
dividend: 13%
0 debt
150 m in cash
established: 1981
$Tesla(TSLA.US$
2
1
Medifast's decision to increase marketing spending amid demand headwinds has alarmed investors, leading to a 10.1% drop in the company's stock price, despite exceeding revenue expectations.
1
Medifast's low P/E ratio is likely due to market anticipation of continued poor earnings. The weak earnings outlook is pressuring the stock price downwards. Without improvement, the low P/E ratio and stock price may not rise.
1
1
Recent insider buying at Medifast isn't a strong indicator of stock potential. Modest insider ownership suggests some alignment between management and smaller shareholders, but overall analysis leaves a cautious outlook on the stock.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Howie116 : Insiders own 97% of this